Literature DB >> 11986101

A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome.

Brian P Connolly1, Eugene Y J Ng, J Arch McNamara, Carl D Regillo, James F Vander, William Tasman.   

Abstract

OBJECTIVE: To compare the refractive outcome of eyes treated with cryotherapy for threshold retinopathy of prematurity (ROP) with eyes treated with laser photocoagulation.
DESIGN: Extended follow-up of a randomized controlled clinical trial. PARTICIPANTS: One hundred eighteen eyes from 66 patients were randomly assigned to receive either cryotherapy or laser photocoagulation for threshold ROP. Twenty-five patients (44 eyes treated) were available for follow-up examination 10 years later. INTERVENTION: Cycloplegic autorefraction or retinoscopy was performed. Immersion ultrasound biometry (A-scan) was also performed, and an autokeratometer was used for keratometry. If an A-scan could not be tolerated or the patient was not cooperative, a B-scan through-the-lid biometry was performed. Corneal thickness was measured using optical coherence tomography. MAIN AND SECONDARY OUTCOME MEASURES: Refractive error. In addition, anterior chamber depth, lens thickness, and axial length were measured. Central corneal thickness measurements and keratometric readings were also obtained. RESULT: Eyes treated with cryotherapy were significantly more myopic than those treated with laser photocoagulation. When comparing patients with bilateral treatment, the mean spherical equivalent (SE) of eyes treated with laser was -4.48 diopters (D) compared with a mean SE of -7.65 D for eyes treated with cryotherapy (n = 15 pairs of eyes, P = 0.019). Cryotherapy-treated eyes had a mean axial length of 21.7 mm versus 22.9 mm for laser-treated eyes (P = 0.024, n = 12 pairs of eyes). The anterior chamber depth and lens thickness averaged 2.86 mm and 4.33 mm, respectively, in the cryotherapy-treated eyes compared with 3.42 mm and 3.95 mm in the laser-treated eyes (P < 0.001, n = 12 pairs for both measurements). There were no statistical differences in anterior corneal curvature and central corneal thickness between the two treatment modalities. Crystalline lens power bore the strongest correlation to refractive outcomes in both laser-treated (r = 0.885, P < 0.001) and cryotherapy-treated eyes (r = 0.591, P = 0.026). Although keratometric readings were higher than normal values in these eyes, there was no correlation to the degree of myopia.
CONCLUSIONS: Laser-treated eyes were significantly less myopic than cyrotherapy-treated eyes. Lens power seemed to be the predominant factor contributing to the excess myopia.

Entities:  

Mesh:

Year:  2002        PMID: 11986101     DOI: 10.1016/s0161-6420(01)01015-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  41 in total

1.  Refraction and keratometry in 40 week old premature (corrected age) and term infants.

Authors:  M Snir; R Friling; D Weinberger; I Sherf; R Axer-Siegel
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

2.  Variations in the morphology of retinopathy of prematurity in extremely low birthweight infants.

Authors:  W E Schulenburg; G Tsanaktsidis
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

Review 3.  Laser treatment for retinopathy of prematurity.

Authors:  Samuel K Houston; Charles C Wykoff; Audina M Berrocal; Ditte J Hess; Timothy G Murray
Journal:  Lasers Med Sci       Date:  2011-12-02       Impact factor: 3.161

4.  Diode laser versus cryotherapy in treatment of ROP.

Authors:  M O'Keefe; C Kirwan
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

5.  Change of refractive state and eye size in children of birth weight less than 1701 g.

Authors:  A R O'Connor; T J Stephenson; A Johnson; M J Tobin; S Ratib; A R Fielder
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

6.  Effects of foveal ablation on emmetropization and form-deprivation myopia.

Authors:  Earl L Smith; Ramkumar Ramamirtham; Ying Qiao-Grider; Li-Fang Hung; Juan Huang; Chea-su Kee; David Coats; Evelyn Paysse
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

7.  Visual outcome and refractive status in first 3 years of age in preterm infants suffered from laser-treated Type 1 retinopathy of prematurity (ROP): a 6-year retrospective review in a tertiary centre in Hong Kong.

Authors:  Julie Y C Lok; Wilson W K Yip; Abbie S W Luk; Joyce K Y Chin; Henry H W Lau; Alvin L Young
Journal:  Int Ophthalmol       Date:  2017-01-04       Impact factor: 2.031

Review 8.  Anti-Vascular Endothelial Growth Factor and the Evolving Management Paradigm for Retinopathy of Prematurity.

Authors:  Dana Darwish; Ru-Ik Chee; Samir N Patel; Karyn Jonas; Susan Ostmo; J Peter Campbell; Michael F Chiang; R V Paul Chan
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2018-05-29

9.  Astigmatism and biometric optic components of diode laser-treated threshold retinopathy of prematurity at 9 years of age.

Authors:  C-S Yang; A-G Wang; Y-F Shih; W-M Hsu
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

10.  Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.

Authors:  Luca Filippi; Giacomo Cavallaro; Patrizio Fiorini; Marta Daniotti; Valentina Benedetti; Gloria Cristofori; Gabriella Araimo; Luca Ramenghi; Agostino La Torre; Pina Fortunato; Liliana Pollazzi; Giancarlo la Marca; Sabrina Malvagia; Paola Bagnoli; Chiara Ristori; Massimo Dal Monte; Anna Rita Bilia; Benedetta Isacchi; Sandra Furlanetto; Francesca Tinelli; Giovanni Cioni; Gianpaolo Donzelli; Silvia Osnaghi; Fabio Mosca
Journal:  BMC Pediatr       Date:  2010-11-18       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.